Framework Journal · one stock, one dated entry

Recorded 2025-12-31 · Permanent

Novanta Inc. NOVTU

Titan Ethical

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

In plain words · Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally.

The label
Markup

read at $63.97

Novanta Inc. holds its Markup at $63.97.

PHINPOOPSC
  • PHPhase · the trend structure carries the Markup label
  • INInsiders · no filings inside 60 days, left as found
  • POPositioning · no disclosures inside 60 days, left as found
  • OPOptions · no verdict drawn today, left as found
  • SCScreen · passes the values gate
  • edge confirmed
  • edge broken
  • edge forming

Each arm is one independent read. Conviction is not a single call, it is how many edges converge.

The investor read · the season, not the day

As held on the ledger · 2025-12-31
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 18 days
Price$63.97
ValuationN/A trailing · N/A forward price to earnings
Values screenPASS · score 70.0
Beta1.68

The business, in plain words · what the numbers mean

The fundamentals · plain-English read
Revenue growth10.4%
steady growth
Profit margin5.3%
thin but positive margins
Return on equity5.2%
a modest return on shareholder capital
Debt to equity0.22
minimal debt — a conservative balance sheet
Current ratio3.56
comfortably covers its short-term bills
Beta1.68
much more volatile than the market
Employees3,000

The risks · The things to watch: it already moves more than the market on an average day.

Plain-English interpretation of our own screen data. Analysis, not advice.

Related securities · others in NOVTU's space worth a look

COHR Coherent Corp. KEYS Keysight Technologies GRMN Garmin TDY Teledyne Technologies FTV Fortive TRMB Trimble Inc.

Screened names in the same industry · explore each on its own page.

Where & how to trade · wherever in the world you are

NOVTU trades on Nasdaq. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The trader read · the latest dated commentary

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 44%. Entered 2026-08-07 · Distribution

The dated journal · newest first, never edited

2026-08-07 Distribution · changed $63.97 -5.2% Entry 4

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 44%.

2026-07-18 Markup $67.45 +0.0% Entry 3

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 44%.

2026-07-03 Markup $67.45 +0.0% Entry 2

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Markup $67.45 Entry 1

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $60.85 +7.8% · $1,078 +7.8%
2 months $55.32 +18.5% $0.81 $1,200 +20.0%
3 months $53.21 +23.3% $0.81 $1,248 +24.8%
6 months $54.03 +21.4% $1.53 $1,242 +24.2%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever NOVTU does next, these words stay.

Novanta Inc. · NOVTU · Markup · $63.97
Recorded 2025-12-31 · before the outcome · scored mechanically

All of today's entries See the running score

Get our weekly market brief free.